<DOC>
	<DOCNO>NCT00003173</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining chemotherapy peripheral stem cell transplantation may allow doctor give high dos chemotherapy drug kill tumor cell . PURPOSE : Phase II trial study effectiveness high-dose thiotepa plus peripheral stem cell transplantation treat patient refractory solid tumor .</brief_summary>
	<brief_title>High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation Treating Patients With Refractory Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate efficacy toxicity sequential cycle high dose thiotepa stem cell rescue filgrastim patient malignancy refractory conventional chemotherapy conventional therapy available . - Evaluate effectiveness autologous stem cell restore hematopoiesis follow high dose thiotepa . OUTLINE : Patients stratify type tumor ( neuroectodermal CNS tumor vs non-neuroectodermal CNS tumor vs non-CNS small round blue cell tumor v non-CNS tumor ) . Autologous stem cell obtain prior administration thiotepa . Patients peripheral blood stem cell available may undergo bone marrow harvest instead . Thiotepa administer 3 hour infusion daily 3 consecutive day . Stem cell reinfused approximately 72 hour follow completion thiotepa . Filgrastim administer day follow reinfusion stem cell continue sufficient hematopoietic recovery . The second course thiotepa administer 4 week follow first course patient respond stable disease , adequate stem cell , unacceptable toxicity . Patients receive maximum 2 course . PROJECTED ACCRUAL : Approximately 36 patient accrue study 2 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Malignant solid tumor Must fail conventional treatment conventional therapy available Measurable disease MRI CT scan Intraocular retinoblastoma may measure direct visualization Germ cell tumor may measure tumor marker No know bone marrow involvement PATIENT CHARACTERISTICS : Age : Any age Performance status : Lansky 60100 % patient 16 Karnofsky 60100 % patient 16 Life expectancy : At least 8 week Hematopoietic : Absolute neutrophil count least 1,000/mm^3 Platelet count least 75,000/mm^3 If parameter meet , must adequate stem cell yield Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT SGPT great 2.5 time ULN ( unless liver involvement tumor ) Renal : Creatinine within normal limit OR Creatinine clearance least 70 mL/min Cardiovascular : Fractional shortening great 28 % echocardiogram OR Ejection fraction least 55 % RNCA prior first cycle thiotepa Pulmonary : DLCO great 55 % predict ( required clinical evidence pulmonary dysfunction ) Other : Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Prior bone marrow peripheral blood stem cell rescue allow Chemotherapy : At least 4 week since prior chemotherapy absolute neutrophil count le 1,000/mm^3 platelet count less 75,000/mm^3 , recover ( i.e . adequate stem cell collect predict hematopoietic recovery ) No concurrent chemotherapy except dexamethasone antiedema effect Endocrine therapy : No concurrent use corticosteroid use solely antiemetics Radiotherapy : At least 4 week since radiotherapy absolute neutrophil count le 1,000/mm^3 platelet count less 75,000/mm^3 , recover ( i.e . adequate stem cell collect predict hematopoietic recovery ) No concurrent radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>intraocular retinoblastoma</keyword>
	<keyword>recurrent retinoblastoma</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>recurrent malignant testicular germ cell tumor</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>childhood germ cell tumor</keyword>
	<keyword>stage III ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>extragonadal germ cell tumor</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
</DOC>